ACCENDRA HEALTH INC/VA/·4

May 19, 8:54 AM ET

Pesicka Edward A 4

4 · ACCENDRA HEALTH INC/VA/ · Filed May 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Accendra Health CEO Edward Pesicka Surrenders 17,692 Shares

What Happened
Edward A. Pesicka, President, CEO and a director of Accendra Health (ACH), surrendered 17,692 shares on 2026-05-15 to satisfy tax withholding related to the vesting of restricted stock. The shares were valued at $3.04 each, for a total of about $53,784. This was a tax-withholding disposition (not an open-market sale or purchase).

Key Details

  • Transaction date: 2026-05-15; Filing date: 2026-05-19 (filed within the Form 4 reporting window).
  • Price per share: $3.04; Total value: ~$53,784.
  • Shares surrendered/disposed: 17,692.
  • Shares owned after the transaction: not specified in this filing.
  • Footnote: F1 — shares were surrendered to the issuer to satisfy tax withholding obligations in connection with restricted stock vesting.
  • Transaction code: F (tax withholding).

Context
This is a routine cashless settlement to cover taxes on vested restricted stock and does not necessarily signal a change in the insider's view of the company. For retail investors, outright purchases by insiders are generally more indicative of bullish sentiment; tax-withholding surrenders are common and largely administrative.

Insider Transaction Report

Form 4
Period: 2026-05-15
Pesicka Edward A
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-05-15$3.04/sh17,692$53,7841,072,785 total
Footnotes (1)
  • [F1]Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Signature
Edward A. Pesicka, by Rosemarie France POA|2026-05-19

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES